Xencor, Inc. (XNCR)
NASDAQ: XNCR · Real-Time Price · USD
23.72
+0.09 (0.38%)
Nov 20, 2024, 4:00 PM EST - Market closed
Xencor Employees
Xencor had 280 employees as of December 31, 2023. The number of employees decreased by 1 or -0.36% compared to the previous year.
Employees
280
Change (1Y)
-1
Growth (1Y)
-0.36%
Revenue / Employee
$304,157
Profits / Employee
-$708,000
Market Cap
1.66B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Fortrea Holdings | 18,000 |
10x Genomics | 1,259 |
Galapagos NV | 1,123 |
GoodRx Holdings | 694 |
Clover Health Investments | 552 |
Recursion Pharmaceuticals | 500 |
Immunocore Holdings | 497 |
Dynavax Technologies | 408 |
XNCR News
- 14 days ago - Xencor Reports Third Quarter 2024 Financial Results - Business Wire
- 17 days ago - Xencor Doses First Subject in Phase 1/2 Study of XmAb®942 in Development for Patients with Inflammatory Bowel Disease - Business Wire
- 6 weeks ago - Xencor Presents Preclinical Data on XmAb942, a High-Potency Extended Half-Life Anti-TL1A Antibody, to be Developed for Patients with Inflammatory Bowel Diseases - Business Wire
- 6 weeks ago - Xencor Announces Upcoming Change to Board of Directors - Business Wire
- 2 months ago - Xencor Announces Closing of Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares - Business Wire
- 2 months ago - Xencor: Vudalimab Development Along With Hidden Gem Candidate - Seeking Alpha
- 2 months ago - Xencor Announces Pricing of $175 Million Public Offering of Common Stock - Business Wire
- 2 months ago - Xencor Announces Proposed Public Offering of Common Stock - Business Wire